Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Q0LF
|
|||
| Former ID |
DIB006797
|
|||
| Drug Name |
Vitatropin
|
|||
| Synonyms |
HL-032; Vitatropin (oral, growth disorders); Vitatropin (oral, growth disorders), HanAll; Engineered hGH (oral, growth disorders), Nautilus/HanAll; Engineered human growth hormone (oral, growth disorders), Nautilus/HanAll; Vitatropin (oral, growth disorders), Nautilus/HanAll
Click to Show/Hide
|
|||
| Indication | Growth failure [ICD-11: LD2F.1Y] | Phase 1 | [1] | |
| Company |
Nautilus Biotech SA
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01440686) Safety, Pharmacokinetics and Pharmacodynamics Study of HL-032 in Healthy Male Volunteers. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.